Investor Service Announcement no. 2/2007 Hørsholm, Denmark, 16 May 2007 LifeCycle Pharma To Present at BioEquity Europe 2007 Biotechnology Conference Summary: LifeCycle Pharma to Present at BioEquity Europe 2007 Biotechnology Conference LifeCycle Pharma A/S (OMX:LCP) today announced that its President and CEO, Dr. Flemming Ornskov, will be presenting a company update at the BioEquity Europe 2007 Biotechnology Conference on 22 May 2007 at 10:25 local time in room Megalithic 1. The two-day conference is being held at the Radisson SAS Hotel in Glasgow, Scotland. The conference will feature presentations from select European companies. For further information please contact: LifeCycle Pharma A/S Michael Wolff Jensen Executive Vice President and CFO Tel. +45 40 74 62 44 ---oo0oo--- About LifeCycle Pharma A/S: LifeCycle Pharma, headquartered in Hørsholm, Denmark, is an emerging pharmaceutical company with a broad and late stage product pipeline in therapeutic areas of cholesterol management, hypertension, organ transplant and autoimmune diseases. LifeCycle Pharma's product candidates are proprietary and designed to improve the quality of existing drugs by enhancing the release and absorption of drugs in the human body. LifeCycle Pharma's proprietary technology platform, MeltDose® technology, offers lower dosing, reduced side effects and improved safety and patient compliance, as well as reduced product development time and development costs. LifeCycle Pharma is listed on the OMX Nordic Exchange under the trading symbol (LCP). Please visit www.lcpharma.com for further information about LifeCycle Pharma A/S.
LifeCycle Pharma To Present at BioEquity Europe 2007 Biotechnology Conference
| Source: Veloxis Pharmaceuticals A/S